Priori | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,099 results for “Priori”

Trials

View all 2466 →

A Priori Diagnosis and Diagnostic Errors

156 participants · First posted Dec 9, 2020

The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation

First posted Nov 28, 2011

A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

428 participants · First posted Dec 12, 2011

Drugs

View all 23 →

MMR-varicella zoster virus vaccine (GlaxoSmithKline)

Measles, mumps, and rubella virus vaccine, live (GlaxoSmithKline)

Helicobacter pylori vaccine

Organizations

FIRST PRIORITY INCORPORATED

United States

Tameside & Glossop Community & Priority Services N H S Trust

United Kingdom

Probi AB

Sweden

News

View all 3605 →

APOE-Stratified GWAS Uncovers New Alzheimer's Risk Loci and Supports A Priori APOE Stratification in AD Trials

Researchers Enhance Lentiviral Vector Potency for Liver Gene Therapy

Solid Biosciences Receives FDA and Health Canada Approval for First-in-Class Gene Therapy Targeting Fatal Heart Rhythm Disorder

Page 1 of 610